Keywords: genentech, third-qtr, revenues, jump, biotechnology, major, posted
Genentech third-qtr revenues jump 24%
Article | 12 October 2001
US biotechnology major Genentech has posted a 22% increase in net incomefor the third quarter of 2001 to $105.4 million (excluding charges resulting ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
